Data / Form D filings / CROWN BIOSCIENCE, INC
CROWN BIOSCIENCE, INC: Form D filings
CROWN BIOSCIENCE, INC, a biotechnology company in Santa Clara, CA, filed 3 Form D notices with the SEC between 2011 and 2013. The latest, on September 13, 2013, reports $30.5 million sold of a $32.2 million offering to 14 investors.
Find out what CROWN BIOSCIENCE, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3375 Scott Boulevard, Suite 108, Santa Clara, CA, 95054
- Phone
- (603) 583-4408
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1381815
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2013 | Amendment | $32,154,281 | $30,466,178 | $1,688,103 | 14 | Apr 18, 2011 | sec.gov |
| May 19, 2011 | Amendment | $28,800,000 | $28,800,000 | $0 | 14 | Apr 18, 2011 | sec.gov |
| May 2, 2011 | New notice | $28,800,000 | $27,800,000 | $1,000,000 | 14 | Apr 18, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Alexander Lo | Director | |
| C.K. Alexander Cheng | Director | |
| Lee Alexander Ting | Director | |
| Jean-Pierre Alexander Wery | Executive Officer | |
| Hongbo Alexander Lu | Director | |
| Guoliang Alexander Yu | Executive Officer | |
| Nisa Alexander Lin | Director | |
| Sandy Alexander Chau | Director | |
| Yue Alexander Wu | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Sep 9, 2013 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CROWN BIOSCIENCE, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.